Boehringer to Build $52M Facility

PETERSBURG, VA-Boehringer Ingelheim Chemicals Inc., a subsidiary of Germany’s Boehringer Ingelheim Corp., has announced the initial $52 million phase of a three-segment expansion plan that could cost as much as $260 million upon its scheduled completion in 2011. The total investment to realize the massive increase of Boehringer’s chemical manufacturing plant in Petersburg Industrial Park will mark the largest biotech investment here. Boehringer is not yet revealing the size of the proposed addition, however the growth endeavor is expected to create over 100 new positions.

“This is the latest in a string of mega biotechnology investments in Virginia, following the Howard Hughes Medical Institute campus in Loudoun County, and the Eli Lilly investment in Prince William County,” says Virginia Gov. Mark R. Warner.